Drugs Clinical Trials for Spinal Cord Injury

SCI.help tracks 283 spinal cord injury clinical trials studying drugs, and 23 are open to new participants. Each links to its full ClinicalTrials.gov record. Last refreshed 2026-09-12.

⚠️
This is research, not treatment. A clinical trial is a study. It may involve a placebo, carries unknown risks, and is not a substitute for proven care. Be wary of any "trial" that charges you to take part. Talk with your SCI doctor before enrolling, and read the full eligibility and risks on ClinicalTrials.gov. Not medical advice.

Open these in the Trials Finder → Add a target (walking, bladder, pain…), a state, or a status filter.

Other treatment categories

Browse by state


Open and recruiting (23)

These trials are recruiting, about to recruit, or enrolling by invitation. Status comes straight from ClinicalTrials.gov and can change without notice.

  • RecruitingNCT07024407

    A Study of Andecaliximab in People With Spinal Cord Injury at Risk for Bone Growth Outside of the Normal Skeleton.

    This is an open-label study of andecaliximab in participants at risk of developing bone where bone should not be, such as in muscle, tendons, and other soft tissues following traumatic spinal cord injury.

    1 US site · Colorado
  • Not yet recruitingNCT07799532

    A Trial Investigating the Efficacy and Safety of NVG-291 in Subjects With Chronic Spinal Cord Injury

    The goal of this clinical trial is to learn if NVG-291 can improve function in adults with chronic cervical motor-incomplete spinal cord injury. It will also learn about the safety of NVG-291.

    DrugsSafetyBlood PressureHand MovementMotor FunctionQuality of LifeSpasticityTemperature Control
    18 US sites · Alabama, California, Colorado, Connecticut…
  • Not yet recruitingNCT07722962

    Additional Phase 3 Study of KP-100IT in Subjects With Acute Spinal Cord Injury

    This is a Phase 3, multicenter, open-label, single-arm additional study to evaluate the efficacy of intrathecal KP-100IT in patients with acute spinal cord injury.

    DrugsArm MovementMotor FunctionSensory Function
    Japan
  • RecruitingNCT05906056

    Continuous Passive Motion Versus Heterotopic Ossification

    The investigators hypothesize that Heterotopic Ossification (HO) formation can be suppressed if the application of a Continuous Passive Motion (CPM) device can be performed for a substantial amount of time.

    Greece
  • RecruitingNCT06654804

    Contrast-enhanced Ultrasound in the Treatment of Acute Spinal Cord Injury

    Patients with traumatic spinal cord injury (tSCI) often suffer from spinal cord swelling inside the thecal sac, which contains the spinal cord and surrounding fluid, leading to increased pressure on the spinal cord tissue and decreased spinal cord blood flow at the site of injury.

    1 US site · Washington
  • Not yet recruitingNCT07643974

    Coupled Gentamicin-Lactobacillus Rhamnosus in NLUTD

    The main objective of the proposed research study is to determine in men and women with spinal cord injury/disease and neurogenic bladder whether the dose of coupled gentamicin \& Lactobacillus rhamnosus GG affects the recolonization of the bladder, and whether the rate of success differs by sex.

    DrugsBladder Function
    2 US sites · District of Columbia, Pennsylvania
  • RecruitingNCT04906928

    Evaluation of New MRI Sequences Including 3D-FGAPSIR for the Optimization of Inflammatory Spinal Cord Lesions Research

    * verification of inclusion and non-inclusion criteria * information and collection of consent * standard imaging protocol prescribed as part of the usual treatment: sagittal T1 and T2 slices after injection of contrast product (Gadolinium), 3D STIR and 3D PSIR sequence.

    France
  • RecruitingNCT06999434

    Exploring the Utility of [18F]3F4AP for Demyelination Imaging

    The overall objective is to obtain an assessment of the pharmacokinetics of \[18F\]3F4AP in healthy volunteers and subjects with demyelinating diseases such as mild cognitive impairment (MCI), Alzheimer's Disease (AD), Multiple Sclerosis (MS), Spinal Cord Injury (SCI) and Spinal radiculopathy (SR).

    1 US site · Connecticut
  • RecruitingNCT07308808

    Intravesical Lactobacillus Crispatus: Clinical Safety and Microbiome Evaluation

    The goal of this clinical trial is to determine whether Lactobacillus crispatus strains isolated from the lower urinary tracts of adult women can be used as an antibiotic-sparing treatment for urinary symptoms and urinary tract infection (UTI) among adults with neurogenic lower urinary tract…

    DrugsBladder Function
    1 US site · District of Columbia
  • Not yet recruitingNCT07227285

    Long-term Follow-up Study of Patients Who Received EG110A, a Non-replicative Herpes Simplex Virus 1-derived Gene Therapy

    The aim of this study is to continue following participants who have received EG110A during five years to know how it is tolerated in humans, any side-effects it may cause and what might be an effective dose over five years.

    DrugsBladder Function
    4 US sites · California, Michigan, Pennsylvania, Texas
  • Not yet recruitingNCT07272967

    Metformin in Preventing Secondary Gliosis Following Acute Thoraco-Lumbar Spinal Cord Injury

    Background: Spinal cord injury (SCI) is a major global health problem, with thoraco-lumbar injuries often leading to paraplegia and incomplete neurological recovery. The glial scar, resulting from astrocyte activation at the injury site, constitutes a major barrier to axon regeneration.

    Egypt
  • Not yet recruitingNCT07739043

    NeuroRise: Intrathecal CE-1 Treatment for Traumatic SCI

    The purpose of this study is to assess the safety and tolerability of intrathecal administration of CE-1 at a weight-based dose (cells/kg BW), capped at a maximum total dose of 1×10⁸ cells in 10 mL, with administered volume calculated using M = 0.167 mL/kg BW.

    1 US site · Illinois
  • RecruitingNCT05491525

    Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC

    The purpose of this study is to evaluate the safety, efficacy, and PK of Vibegron in pediatric participants with NDO who are regularly using CIC

    DrugsBladder Function
    38 US sites · Arkansas, California, Colorado, Florida…
  • RecruitingNCT07390591

    Patient and Caregiver Perspectives on Intravesical Instillations for Urinary Symptoms

    The goal of this observational qualitative study is to learn about the experiences and perspectives of patients with neurogenic lower urinary tract dysfunction (NLUTD) and their caregivers regarding different types of intravesical instillations used for urinary health.

    DrugsBladder Function
    1 US site · District of Columbia
  • RecruitingNCT07625332

    Pilot Study of Galantamine to Treat Metabolic Syndrome in People With Chronic Traumatic Spinal Cord Injury (SCI)

    The purpose of this research study is to measure the tolerability and preliminary efficacy of a drug, galantamine, to treat metabolic syndrome (MetS) by reducing circulating inflammation in people with spinal cord injury (SCI). Galantamine is FDA-approved for the treatment of Alzheimer's disease.

    DrugsQuality of Life
    3 US sites · New Jersey, New York
  • Not yet recruitingNCT07527728

    Postoperative Neurological Recovery and Risk Factor Analysis in Patients With Paralysis Due to Spinal Metastases

    Metastatic spinal tumors represent a common and devastating complication in patients with advanced solid malignancies. Up to 40% of cancer patients may develop spinal metastases during the course of their disease, often resulting in intractable pain, neurological deficits, and spinal instability.

    DevicesDrugsEpidural StimulationObservationalSurgical ProcedureBladder FunctionBowel FunctionMotor FunctionPain ManagementQuality of LifeSpasticity
  • RecruitingNCT05484557

    Prevention of Thromboembolism Using Apixaban vs Enoxaparin Following Spinal Cord Injury

    Currently, Enoxaparin is the usual prophylactic anticoagulant treatment at the acute and sub-acute phases of spinal cord injury (SCI). Patients at the sub-acute phase of SCI (rehabilitation) will be given either Enoxaparin 40 mg/day (control) or Apixaban 2.5-5 mg twice a day.

    Israel
  • RecruitingNCT07251491

    Psilocybin to Treat Depression in Spinal Cord Injury

    The main goal of this study is to determine if psilocybin is safe for use in people with SCI. The study will measure how people with SCI respond to three psilocybin doses: low (5mg), medium (10mg), and high (25mg).

    DrugsMental Health
    1 US site · New York
  • RecruitingNCT07384052

    Safety and Feasibility of Intranasal Insulin in Patients With Spinal Cord Injury

    The purpose of this study is to find out whether insulin, a drug approved by the FDA for the treatment of diabetes mellitus, is safe when administered as a nasal spray (intranasally) to people who have experienced a spinal cord injury.

    1 US site · Minnesota
  • Not yet recruitingNCT05739734

    Safety of CRIS100 on Treatment Spinal Cord Injury

    The goal of this clinical trial is to test CRIS100 treatment in participants with acute thoracic spinal cord injury. The main questions it aims to answer are: * safety of CRIS100 * efficacy of CRIS100 Participants will receive 100 mcg CRIS100 in the epicenter of the spinal injury, within 72 hours…

  • RecruitingNCT05018793

    Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Versus Cultured Allogeneic Adult Umbilical-cord Derived Mesenchymal Stem Cell Intrathecal Injection for SCI

    This trial will study the safety and efficacy of intrathecal injection of cultured autologous adult adipose derived mesenchymal stem cells versus cultured allogeneic adult umbilical-cord derived mesenchymal stem cells for the treatment of spinal cord injury

    Antigua and Barbuda, Greece
  • Not yet recruitingNCT07742553

    Testosterone Therapy With or Without Finasteride After Spinal Cord Injury: TRT-SCI Trial

    Spinal cord injury (SCI) results in lower limb muscle loss, bone loss, and high fat mass that impede the recovery of physical function, increase bone fracture risk, and worsen health and quality of life.

    DrugsBone StrengthLeg MovementMotor FunctionQuality of LifeWalking Function
    4 US sites · Colorado, Florida, New York
  • RecruitingNCT06782464

    Upper Limb Nerve Cryoneurolysis is Non Inferior to the Usual Care and Has Therapeutic Add Value in Dealing With Shoulder Pain and Functional Problems Caused by Spasticity and Motor Impairment

    This trial is part of the spastiCRYO clinical research project. The primary objective of this clinical trial is to test the hypothesis: "Upper limb nerve cryoneurolysis is non inferior to the usual care and has therapeutic add value in dealing with shoulder pain and functional problems caused by…

    DrugsElectrical StimulationRehabilitationArm MovementPain ManagementQuality of LifeSensory FunctionSpasticity
    Luxembourg

Running, but closed to new participants (2)

Active studies that are no longer enrolling. Useful for seeing where the field is heading.

  • Active, not recruitingNCT07792616

    Electrical Neuromodulation for Modifying Spinal Network Involved in Spasticity

    Muscle stiffness and muscle spasms are common after spinal cord injury. They can interfere with washing and dressing, moving between the bed and a wheelchair, walking, and sleep, and they can cause pain.

    2 US sites · Mississippi
  • Active, not recruitingNCT07295067

    Extracellular Vesicles for the Treatment of Syringomyelia

    This is a open-label, single-arm, dose escalation phase I clinical trial. The goal of this clinical trial is to evaluate the safety and preliminary efficacy of Intrathecal injection human umbilical cord-derived mesenchymal stromal cell-derived extracellular vesicle (hUC-MSC-sEV) in syringomyelia.

    DrugsSafetyStem CellsBreathing Function
    China

Completed and closed (258)

Completed, terminated, withdrawn, or last reported with an unknown status. Completed trials are where published results come from.

  • Completed NCT02025179 12 Month Extension Study of the Effect of Teriparatide on Bone in People With Chronic Spinal Cord Injury (SCI)
  • Completed NCT02586649 24hr Effects of Tiotropium Bromide in Tetraplegia
  • Completed NCT00407745 A 17-Week Trial To Assess Pregabalin For The Treatment Of Nerve Pain Due To Spinal Cord Injury
  • Completed NCT01477736 A Comparison Study of Oxybutynin and Botulinum Toxin for Neurogenic Detrusor Overactivity
  • Completed NCT00426842 A Dose Response Trial Using 5 and 10 Mg of Midodrine Hydrochloride
  • Completed NCT01354158 A Dose Titration of Droxidopa in Patients With Spinal Cord Injury
  • Withdrawn NCT01297608 A Double Blinded Study to Examine the Effect of Coated Suppositories on Fecal Incontinence in Patients With Spinal Cord Injury
  • Suspended NCT03229031 A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Safety and Efficacy of ES135 in Subjects With Spinal Cord Injury
  • Completed NCT05308953 A Phase I Safety Study of NVG-291 in Healthy Adults
  • Completed NCT00500812 A Safety Study for Cethrin (BA-210) in the Treatment of Acute Thoracic and Cervical Spinal Cord Injuries
  • Completed NCT00557973 A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
  • Completed NCT01748695 A Safety, Tolerability and Efficacy Study of V158866 in Central Neuropathic Pain Following Spinal Cord Injury
  • Completed NCT00224029 A Study Evaluating Oxybutynin in Patients With Neurogenic Overactive Bladder Associated With a Neurological Condition
  • Completed NCT00654082 A Study Evaluating the Efficacy and Safety of Sildenafil in Men With Traumatic Spinal Cord Injury and Erectile Dysfunction
  • Completed NCT00248807 A Study of Blood Pressure and Blood Supply to the Brain in Persons With a Spinal Cord Injury.
  • Completed NCT01606202 A Study of Cannabis Based Medicine Extracts and Placebo in Patients With Pain Due to Spinal Cord Injury
  • Unknown NCT00725790 A Study to Evaluate the Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction Caused by Spinal Cord Injury
  • Terminated NCT00712322 A Two-week Open-label Pharmacodynamic and Pharmacokinetic Study of Multiple Doses of a Darifenacin Liquid Oral Suspension in Children (2 - 15 Years) With Neurogenic Detrusor Overactivity
  • Terminated NCT01750684 AC105 in Patients With Acute Traumatic Spinal Cord Injury
  • Terminated NCT03780829 AIH for Spinal Cord Repair
  • Completed NCT03989440 AXER-204 in Participants With Chronic Spinal Cord Injury
  • Withdrawn NCT02970773 Absorption of Rivaroxaban in Patients With Cervical Spinal Cord Injury
  • Completed NCT02307526 Acetylcholinesterase Inhibition and Orthostatic Hypotension in SCI
  • Completed NCT04052776 Acute Effects of Pharmacological Neuromodulation on Leg Motor Activity in Patients With SCI Treated With EES
  • Completed NCT02441179 Acute Intermittent Hypoxia and Body Weight Supported Treadmill Training for Incomplete Spinal Cord Injury Patients
  • Completed NCT00406016 Acute Safety, Tolerability, Feasibility and Pharmacokinetics of Intrath. Administered ATI355 in Patients With Acute SCI
  • Unknown NCT01353599 Acute and Chronic Effects of Inhaled Steroids on Pulmonary Function in Persons With Spinal Cord Injury
  • Completed NCT03308565 Adipose Stem Cells for Traumatic Spinal Cord Injury
  • Terminated NCT02508311 Albuterol to Improve Respiratory Strength in SCI
  • Completed NCT01202227 An Open-Label Long-Term Study Of Pregabalin For The Treatment Of Central Neuropathic Pain
  • Terminated NCT03200613 Apixaban For Thromboprophylaxis In Patients With Acute Spinal Cord Injury
  • Completed NCT00667966 Assess Efficacy in Subjects With Traumatic Spinal Cord Injury
  • Completed NCT01274975 Autologous Adipose Derived MSCs Transplantation in Patient With Spinal Cord Injury.
  • Completed NCT02482194 Autologous Mesenchymal Stem Cells Transplantation for Spinal Cord Injury- A Phase I Clinical Study
  • Unknown NCT03169582 Avanafil Versus Sildenafil in Spinal Cord Injury Erectile Dysfunction
  • Completed NCT00652262 BAY38-9456 - Supportive Trial for Spinal Injury
  • Unknown NCT02604927 Beta-alanine Supplementation and Its Effects on Performance, Muscle Carnosine Content and Safety in Athletes With Spinal-cord Injury
  • Completed NCT02761707 Biomarkers in Neural Disorders
  • Completed NCT01498809 Blood Pressure and Brain Blood Flow Regulation After Midodrine Administration in Those With Spinal Cord Injury
  • Completed NCT02307565 Blood Pressure, Cerebral Blood Flow and Cognition in Spinal Cord Injury
  • Completed NCT01822535 Body Temperature in Persons With Tetraplegia When Exposed to Cold
  • Completed NCT02298660 Botox for Neurogenic Detrusor Overactivity and the Prevention of Autonomic Dysreflexia Following SCI
  • Terminated NCT00711087 Botox-A Injection to Improve Bladder Function in Early Spinal Cord Injury (#H-20344)
  • Terminated NCT01911377 Botulinum Toxin Type A for Treating Allodynic Pain in SCI and MS
  • Withdrawn NCT00262496 Botulinum-A Toxin Injection for Detrusor Hyperreflexia in Spinal Cord Injury: A Non-Surgical Approach.
  • Completed NCT01567605 Bowel Care and Cardiovascular Function After Spinal Cord Injury
  • Completed NCT05639946 Brivaracetam to Reduce Neuropathic Pain in Chronic SCI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
  • Completed NCT04379011 Brivaracetam to Reduce Neuropathic Pain in Chronic Spinal Cord Injury
  • Completed NCT04057456 Cannabinoids and an Anti-inflammatory Diet for the Treatment of Neuropathic Pain After Spinal Cord Injury
  • Completed NCT02441660 Capsaicin 8% Patch for Spinal Cord Injury Neuropathic Pain
  • Completed NCT05054803 Cell Therapy for Chronic Traumatic Cervical Incomplete Spinal Cord Injury
  • Withdrawn NCT02053883 Cethrin in Acute Cervical Spinal Cord Injury
  • Completed NCT00006428 Chronic Pain in Spinal Cord Injury
  • Completed NCT01435798 Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan Dose Response Clinical Trial
  • Completed NCT02218203 Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan/Lidocaine Combination Clinical Trial
  • Completed NCT00629642 Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple Sclerosis
  • Completed NCT04148573 Clinical Trial to Evaluate Safety, Tolerability and Efficacy of NFX88 in SCI
  • Completed NCT01621113 Combination Therapy With Dalfampridine and Locomotor Training for Chronic, Motor Incomplete Spinal Cord Injury
  • Completed NCT00800462 Comparative Study of the Efficacy and Safety of Muscarinic M3 Receptors Antagonists in the Treatment of Neurogenic Detrusor Overactivity
  • Terminated NCT01433159 Comparison of HP011-101 to Standard Care for Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury
  • Completed NCT00047580 Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex® (Tizanidine Hydrochloride Tablets) Taken While in the Fed State (Just After a Meal) and in the Fasted State (Before a Meal) in Patients With Moderate to Severe Spasticity.
  • Completed NCT01345019 Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma
  • Completed NCT02302157 Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
  • Completed NCT03602014 Dose Response to the Norepinephrine Precursor Droxidopa in Hypotensive Individuals With Spinal Cord Injury
  • Terminated NCT02660138 Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1
  • Terminated NCT02660359 Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 2
  • Completed NCT02195895 Effect of Alendronate on Bone in People With Chronic Spinal Cord Injury (SCI) Previously Treated With Teriparatide
  • Completed NCT01682603 Effect of Botulinum Toxin A on Detrusor Overactivity and Renal Function in Chronic Spinal Cord Injured Patients
  • Completed NCT01222468 Effect of Cannabinoids on Spasticity and Neuropathic Pain in Spinal Cord Injured Persons
  • Completed NCT00871455 Effect of Low-Dose Baclofen Administration on the GH-IGF1 Axis Study
  • Completed NCT00826228 Effect of Parathyroid Hormone (PTH) and Weight-Bearing on Bone in Spinal Cord Injury (SCI)
  • Completed NCT01067391 Effect of Tadalafil (Cialis) on the Cardiovascular System of Spinal Cord Injury (SCI) Males
  • Completed NCT01225055 Effect of Teriparatide, Vibration and the Combination on Bone Mass and Bone Architecture in Chronic Spinal Cord Injury
  • Completed NCT00488969 Effectiveness of Controlled-Release Morphine for Chronic Neuropathic Pain After Spinal Cord Injury
  • Terminated NCT00332319 Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients
  • Completed NCT05447676 Effects of 4-AP on Functional SCI Recovery
  • Suspended NCT04000919 Effects of 5HTP and LDOPA on CNS Excitability After SCI
  • Completed NCT05591001 Effects of Anesthetic Infusion on the Amplitude of Motor Evoked Potential in Pediatrics Undergoing Tethered Spinal Cord Surgeries
  • Unknown NCT01355991 Effects of Anticholinergic or Long-Acting Beta 2 Agonist on FeNO and Pulmonary Function in SCI
  • Completed NCT01600404 Effects of Antimuscarinics on Cognition in Spinal Cord Injury
  • Withdrawn NCT04471714 Effects of Baclofen on Presynaptic Inhibition in Humans
  • Completed NCT02323698 Effects of Caffeine and Intermittent Hypoxia on Leg Function in Human Spinal Cord Injury
  • Completed NCT05008484 Effects of Electrical Stimulation and Vitamin D Supplementation on Bone Health Following Spinal Cord Injury.
  • Completed NCT03482037 Effects of Rec 0/0438 in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Injury
  • Completed NCT05398913 Effects of Rimonabant on Walking Abilities in Incomplete Spinal Cord Injury
  • Completed NCT01201759 Effects of Salsalate on Prandial-Induced Vascular Inflammation After Spinal Cord Injury (SCI)
  • Completed NCT01037088 Effects of Vaporized Marijuana on Neuropathic Pain
  • Completed NCT00167856 Effects of Venlafaxine on Chronic Neuropathic Pain Following Spinal Cord Injury
  • Terminated NCT04815967 Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity
  • Completed NCT01329757 Efficacy and Safety of Growth Hormone Treatment in Spinal Cord Injury
  • Completed NCT00750061 Efficacy and Safety of Lithium Carbonate in the Treatment of Chronic Spinal Cord Injuries
  • Completed NCT00745095 Efficacy and Safety of Standard Oral Colonoscopic Preparations With or Without Neostigmine Compared to Pulse-Irrigation Colonic Lavage
  • Completed NCT00421083 Efficacy and Safety of Tadalafil in Subjects With Erectile Dysfunction Caused by Spinal Cord Injury
  • Terminated NCT00844480 Efficacy and Safety of Zoledronic Acid in Acute Spinal Cord Injury: Prevention of Bone Loss
  • Completed NCT00654680 Evaluating the Efficacy and Safety of Vardenafil in Patients Erectile Dysfunction Solely Secondary to Spinal Cord Injury
  • Completed NCT04256603 Evaluation of Initiation Time on the Efficacy of Gabapentin in Treating Neuropathic Pain in SCI
  • Terminated NCT00561067 Evaluation of Tolerability and Efficacy of Erythropoietin (EPO) Treatment in Spinal Shock: Comparative Study Versus Methylprednisolone (MP)
  • Completed NCT00753948 Exhaled Levels of Nitric Oxide
  • No longer available NCT04278235 Expanded Access to Elezanumab
  • Terminated NCT00786968 Extension Study of Intrathecal Enzyme Replacement Therapy for MPS I
  • Terminated NCT01426555 FES-Rowing Versus Zoledronic Acid to Improve Bone Health in Spinal Cord Injury (SCI)
  • Completed NCT02455336 Fenofibrate Treatment in SCI
  • Completed NCT02676154 Fesoterodine for Amelioration of Autonomic Dysreflexia (AD) Following Spinal Cord Injury (SCI)
  • Completed NCT00507546 Functional Melatonin Replacement for Sleep Disruptions in Individuals With Tetraplegia
  • Completed NCT03931408 Gentamicin Bladder Instillation in Individuals With Spinal Cord Injury Having Chronic Urinary Tract Infections
  • Completed NCT03503513 Gentamicin Bladder Instillations to Prevent Urinary Tract Infections in Patients With Spinal Cord Injury
  • Withdrawn NCT01273428 HP011-101, HP828-101, and Standard Care for Pressure Ulcers
  • Completed NCT00093275 HP184 in Chronic Spinal Cord Injury Subjects
  • Terminated NCT03101982 Hyperbaric Oxygenation (HBO) in Traumatic Spinal Cord Injury. (EOS) - Pilot Study
  • Completed NCT02881957 Hypovitaminosis D in Neurocritical Patients
  • Completed NCT02034331 IR and Microvascular Blood Flow in SCI
  • Completed NCT04049994 Immunomodulation Therapy for Urinary Tract Infections
  • Completed NCT03752749 Impact of Intermittent Hypoxia and Prednisolone on Motor Performance in Persons With SCI
  • Unknown NCT02136823 Impact of Persistent Conductances on Motor Unit Firing in SCI
  • Completed NCT02748356 Impact of Probiotics on Urinary Symptoms in Spinal Cord Injury SCI and SB
  • Completed NCT02748317 Impact of Probiotics on Urinary Symptoms in Spinal Cord Injury SCI and SB
  • No longer available NCT04064957 Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for Spinal Cord Injury
  • No longer available NCT03925649 Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for Treatment of SCI
  • Completed NCT04243044 Influence of Transcutaneous Spinal Stimulation Intensity on Spasticity After SCI
  • Completed NCT04020770 Influence of Upper Extremity Vibration on Spasticity and Function in Persons With Tetraplegia
  • Terminated NCT02736890 Injecting Botulinum Toxin A Underneath the Skin to Treat Spinal Cord Pain in Patients With Spinal Cord Injury
  • Completed NCT01637766 Intra-arterial Chemotherapy for Spinal Metastases
  • Completed NCT02903823 Intrathecal (IT) Baclofen Drug Distribution
  • Completed NCT03003364 Intrathecal Administration of Expanded Wharton's Jelly Mesenchymal Stem Cells in Chronic Traumatic Spinal Cord Injury
  • Completed NCT02705950 Intrathecal Baclofen (ITB) Bolus on Neuropathic Pain (NP). Preliminary Study.
  • Terminated NCT00215527 Intrathecal Enzyme Replacement Therapy for Spinal Cord Compression in Mucopolysaccharidosis (MPS) I
  • Completed NCT01624779 Intrathecal Transplantation Of Autologous Adipose Tissue Derived MSC in the Patients With Spinal Cord Injury
  • Completed NCT01091727 Intravesical Injection of Botulinum Toxin A Versus Saline for Neurogenic Detrusor Overactivity
  • Completed NCT04373512 Intravesical Lactobacillus to Reduce Urinary Symptoms After Spinal Cord Injury
  • Completed NCT00320281 Investigating Botulinum Toxin A to Treat Acute Neck/Upper Shoulder Pain Following a New Spinal Cord Injury.
  • Completed NCT00252954 Levetiracetam in Chronic Neuropathic Pain Following Spinal Cord Injury
  • Completed NCT01471613 Lithium, Cord Blood Cells and the Combination in the Treatment of Acute & Sub-acute Spinal Cord Injury
  • Completed NCT02635893 Lower Limb Function After Spinal Cord Injury
  • Completed NCT01117090 Measuring Signatures in the Fluid Surrounding the Spinal Cord in Patients Who Have Problems With Intrathecal Drug Delivery
  • Completed NCT00001661 Mechanisms of Human Plasticity in the Human System
  • Completed NCT00004759 Methylprednisolone Given by 24-Hour or 48-Hour Infusion Versus Tirilazad for Acute Spinal Cord Injury
  • Completed NCT00559494 Minocycline and Perfusion Pressure Augmentation in Acute Spinal Cord Injury
  • Unknown NCT01828203 Minocycline in Acute Spinal Cord Injury (MASC)
  • Completed NCT01538693 Molecular Markers of Neuroplasticity During Exercise in People With Incomplete Spinal Cord Injury
  • Completed NCT02052024 Myobloc Atrophy Study
  • Completed NCT03935321 NISCI - Nogo Inhibition in Spinal Cord Injury
  • Completed NCT05965700 NVG-291 in Spinal Cord Injury Subjects
  • Completed NCT01357980 Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis
  • Completed NCT01579500 Neuropathic Pain Study With Botulinum Toxin A in Spinal Cord Injury Patients
  • Completed NCT03292315 Once Weekly GLP-1 in Persons With Spinal Cord Injury
  • Completed NCT04400747 Oral Colecalciferol Treatment in Spinal Cord Lesion
  • Completed NCT03624218 Outcomes After Spinal Cord Injury (OASIS)
  • Terminated NCT00101361 Oxandrolone to Heal Pressure Ulcers
  • Completed NCT04707144 Performance Evaluation of a 3D PSIR Sequence in MRI at 1.5T
  • Completed NCT04618978 Periodic Leg Movements' Diagnosis in Spinal Cord Injury: Actigraphy as an Alternative for Polysomnography?
  • Completed NCT04027972 Pharmacokinetics of Neostigmine and Glycopyrrolate
  • Completed NCT05708274 Pharmacological Agents for Chronic Spinal Cord Injury (SCI)
  • Completed NCT02193334 Phase I/II Study of KP-100IT in Acute Spinal Cord Injury
  • Terminated NCT01131884 Pilot Study of Fosamax in Spinal Cord Injury
  • Completed NCT00175682 Prazosin Vibrostimulation Autonomic Dysreflexia and Spinal Cord Injury Study
  • Unknown NCT01479556 Pregabalin for the Treatment and Prevention of Spinal Cord Injury Neuropathic Pain
  • Completed NCT02001558 Pressure Ulcer Healing With Microcyn
  • Completed NCT02591901 Preventing UTIs in Chronic Neurogenic Bladder Dysfunction (Mix Methods)
  • Completed NCT01698138 Prevention of Bladder Dysfunction in Acute Spinal Cord Injury
  • Completed NCT02325414 Prevention of Bone Loss After Acute SCI by Zoledronic Acid
  • Unknown NCT01813240 Prevention of Imminent Paralysis Following Spinal Cord Trauma or Ischemia by Minocycline: A Multi-center Study in Israel With IDF Primary Care Involvement
  • Completed NCT00237770 Prevention of Low Blood Pressure in Persons With Tetraplegia
  • Completed NCT00309114 Prevention of Urinary Tract Infection (UTI) in Persons With Spinal Cord Injury (SCI)
  • Completed NCT00592384 Project to Improve Symptoms and Mood in People With Spinal Cord Injury
  • Completed NCT01849822 Providing Brain Control of Extracorporeal Devices to Patients With Quadriplegia
  • Completed NCT00223860 Provocative Testing Using LHRH and hCG of the Pituitary-Gonadal Axis in Persons With Spinal Cord Injury.
  • Terminated NCT03655080 Pulsed Abraxane and Radiotherapy for Improving and Maintaining Ambulation After Cancer-Related Cord Compression
  • Completed NCT00623376 Randomized Double Blind Cross Over Study for Nabilone in Spasticity in Spinal Cord Injury Persons
  • Completed NCT03906721 Reduction of Opioid Dose Using Conditioning & Open-Label Placebo (COLP) in Intensive Rehabilitation
  • Completed NCT01652040 Resistance Training and Testosterone After Spinal Cord Injury
  • Terminated NCT01597518 Riluzole in Spinal Cord Injury Study
  • Completed NCT00150696 Risedronate for the Prevention of Osteoporosis in People With Spinal Cord Injury.
  • Completed NCT00138866 Risedronate for the Treatment of Osteoporosis for People With Spinal Cord Injury
  • Completed NCT02458469 Role of Enhancing Serotonin Receptors Activity for Sleep Apnea Treatment in Patients With SCI
  • Completed NCT04799782 Role of Mirtazapine in Ameliorating Sleep Disordered Breathing
  • Completed NCT04708886 Romosozumab in Women With Chronic SCI
  • Completed NCT06565351 S-cystatin C vs.Injection Clearance Measurements to Estimate Kidney Function in Patients With Spinal Cord Injuries
  • Completed NCT04295538 Safety And Efficacy Study Of Intravenous (IV) Administration Of Elezanumab To Assess Change In Upper Extremity Motor Score (UEMS) In Adult Participants With Acute Traumatic Cervical Spinal Cord Injury (SCI)
  • Completed NCT02096913 Safety Study of Ibuprofen to Treat Acute Traumatic Spinal Cord Injury
  • Completed NCT01135108 Safety and Efficacy Study of KAI-1678 to Treat Pain in Subjects With Spinal Cord Injury
  • Terminated NCT01676441 Safety and Efficacy of Autologous Mesenchymal Stem Cells in Chronic Spinal Cord Injury
  • Withdrawn NCT00610337 Safety and Efficacy of Cethrin® in Adult Subjects With Acute Cervical Spinal Cord Injury
  • Completed NCT00835224 Safety and Efficacy of L-NAME and Midodrine to Increase MAP
  • Completed NCT00041717 Safety and Efficacy of Oral Fampridine-SR for the Treatment of Spasticity Resulting From Spinal Cord Injury
  • Completed NCT01683838 Safety and Efficacy of Oral Fampridine-Sustained Release (SR) for the Treatment of Spasticity Resulting From Spinal Cord Injury
  • Completed NCT00856440 Safety and Efficacy of Routine Colonoscopy Preparations
  • Terminated NCT01598103 Safety and Efficacy of SAF312 in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Lesions
  • Withdrawn NCT02237547 Safety and Feasibility Study of Cell Therapy in Treatment of Spinal Cord Injury
  • Completed NCT01046786 Safety and Feasibility of Umbilical Cord Blood Cell Transplant Into Injured Spinal Cord
  • Completed NCT04096950 Safety and Pharmacokinetics Study of MT-3921 in Spinal Cord Injury
  • Completed NCT00431171 Safety and Pharmacokinetics Study of Oral Lithium in Patients With Chronic Spinal Cord Injury
  • Terminated NCT00531466 Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Due to Spinal Cord Injury
  • Completed NCT03168828 Safety and Tolerability of TAR-302-5018 in Subjects With Neurogenic Detrusor Overactivity Resulting From Spinal Cord Injury
  • Completed NCT00876889 Safety of Riluzole in Patients With Acute Spinal Cord Injury
  • Unknown NCT01788969 Serotonergic Modulation of Motor Function in Subacute and Chronic SCI
  • Completed NCT06117020 Single and Multiple Ascending Dose Study of MTR-601 in Healthy Individuals
  • Withdrawn NCT02585765 Skin Blood Flow Response to Insulin Iontophoresis in Pressure Ulcers of SCI
  • Completed NCT02537899 Spinal Cord Injury - Assessing Tolerability and Use of Combined Rehabilitation and NeuroAiD
  • Terminated NCT02524379 Spinal Cord Injury Neuroprotection With Glyburide
  • Completed NCT03702010 Spinal Cord Stimulation in Patients With Post-Laminectomy Syndrome in Testing Phase

Showing 200 of 258 closed studies. The rest are in the Trials Finder and on the state pages below.


Where this list comes from

Trials are pulled daily from the ClinicalTrials.gov registry and tagged by what they study and what they target. This page reflects the 2026-09-12 refresh of the 2,167 spinal cord injury trials SCI.help tracks. Eligibility criteria, study contacts, exact sites, and results live on each trial's ClinicalTrials.gov record, linked above. The full dataset is public at /data/sci_trials.min.json.

Before contacting a study team, read clinical trials and SCI research, honestly and how to spot a predatory "trial".